|
US5300645A
(en)
|
1993-04-14 |
1994-04-05 |
Eli Lilly And Company |
Tetrahydro-pyrido-indole
|
|
US5858753A
(en)
|
1996-11-25 |
1999-01-12 |
Icos Corporation |
Lipid kinase
|
|
US5939421A
(en)
|
1997-07-01 |
1999-08-17 |
Signal Pharmaceuticals, Inc. |
Quinazoline analogs and related compounds and methods for treating inflammatory conditions
|
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
WO2001085986A2
(en)
|
2000-05-10 |
2001-11-15 |
Icos Corporation |
Phosphatidyl inositol 3-kinase delta binding partner
|
|
DE10043667A1
(de)
|
2000-09-05 |
2002-03-14 |
Merck Patent Gmbh |
2-Guanidino-4-aryl-chinazoline
|
|
CN1253449C
(zh)
|
2000-11-07 |
2006-04-26 |
诺瓦提斯公司 |
作为蛋白激酶c抑制剂的吲哚基马来酰亚胺衍生物
|
|
KR100833371B1
(ko)
|
2001-04-27 |
2008-05-28 |
젠야쿠코교가부시키가이샤 |
헤테로시클릭 화합물 및 이를 유효 성분으로 하는 항종양제
|
|
AR039209A1
(es)
|
2002-04-03 |
2005-02-09 |
Novartis Ag |
Derivados de indolilmaleimida
|
|
KR20050084224A
(ko)
|
2002-12-09 |
2005-08-26 |
더 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
야누스 티로신 키나제 3을 선택적으로 저해하는 방법
|
|
WO2004058756A1
(en)
|
2002-12-27 |
2004-07-15 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa |
Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors
|
|
US20050043239A1
(en)
|
2003-08-14 |
2005-02-24 |
Jason Douangpanya |
Methods of inhibiting immune responses stimulated by an endogenous factor
|
|
US20050054614A1
(en)
|
2003-08-14 |
2005-03-10 |
Diacovo Thomas G. |
Methods of inhibiting leukocyte accumulation
|
|
ES2389203T3
(es)
|
2004-01-12 |
2012-10-24 |
Ym Biosciences Australia Pty Ltd |
Inhibidores de quinasa selectivos
|
|
WO2005070929A1
(en)
|
2004-01-23 |
2005-08-04 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
|
WO2005086814A2
(en)
*
|
2004-03-09 |
2005-09-22 |
The Uab Research Foundation |
Methods and compositions related to regulation of cytokine production by glycogen synthase kinase 3 (gsk-3)
|
|
EP1750714A1
(en)
|
2004-05-13 |
2007-02-14 |
Vanderbilt University |
Phosphoinositide 3-kinase delta selective inhibitors for inhibiting angiogenesis
|
|
LT2612862T
(lt)
|
2004-05-13 |
2017-01-25 |
Icos Corporation |
Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės delta inhibitoriai
|
|
KR100883289B1
(ko)
|
2004-06-11 |
2009-02-11 |
니뽄 다바코 산교 가부시키가이샤 |
암 치료용5-아미노-2,4,7-트리옥소-3,4,7,8-테트라히드로-2ｈ-피리도[2,3-ｄ]피리미딘 유도체 및 관련 화합물
|
|
GB0423653D0
(en)
|
2004-10-25 |
2004-11-24 |
Piramed Ltd |
Pharmaceutical compounds
|
|
US20060128710A1
(en)
|
2004-12-09 |
2006-06-15 |
Chih-Hung Lee |
Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
|
|
EP1844023A1
(en)
|
2004-12-31 |
2007-10-17 |
Sk Chemicals Co., Ltd. |
Quinazoline derivatives for the treatment and prevention of diabetes and obesity
|
|
JP5198256B2
(ja)
|
2005-05-04 |
2013-05-15 |
エボテク エージー |
縮合複素環式化合物、並びにそれらの組成物及び使用
|
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
|
ZA200801822B
(en)
|
2005-08-26 |
2009-09-30 |
Serono Lab |
Pyrazine derivatives and use as p13k inhibitors
|
|
GB0520657D0
(en)
|
2005-10-11 |
2005-11-16 |
Ludwig Inst Cancer Res |
Pharmaceutical compounds
|
|
JP2009520700A
(ja)
|
2005-12-21 |
2009-05-28 |
ペインセプター ファーマ コーポレーション |
依存性イオンチャネルを調節するための組成物および方法
|
|
GB0612630D0
(en)
|
2006-06-26 |
2006-08-02 |
Novartis Ag |
Organic compounds
|
|
US8673929B2
(en)
|
2006-07-20 |
2014-03-18 |
Gilead Sciences, Inc. |
4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
|
|
PT2049502E
(pt)
|
2006-07-28 |
2012-04-02 |
Novartis Ag |
Quinazolinas 2,4-substituídas como inibidores da lípido cinase
|
|
EP1891958A1
(en)
*
|
2006-08-03 |
2008-02-27 |
Universite Pierre Et Marie Curie (Paris Vi) |
Rho/Rock/PI3/Akt kinase inhibitors for the treatment of diseases associated with protozoan parasites.
|
|
EP2441768A1
(en)
|
2006-11-13 |
2012-04-18 |
Eli Lilly & Co. |
Thienopyrimidinones for treatment of inflammatory disorders and cancers
|
|
HRP20160350T1
(hr)
|
2007-03-23 |
2016-05-06 |
Amgen Inc. |
Heterociklički spojevi i njihove uporabe
|
|
MX2009010050A
(es)
|
2007-03-23 |
2009-10-12 |
Amgen Inc |
Derivados de quinolina o quinoxalina 3-sustituidos y su uso como inhibidores de fosfotidilinositol 3-cinasa (p13k).
|
|
CA2680783C
(en)
|
2007-03-23 |
2012-04-24 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
|
WO2008123963A1
(en)
|
2007-04-02 |
2008-10-16 |
Renovis, Inc. |
Pyrid-2-yl fused heterocyclic compounds, and compositions and uses thereof
|
|
JP2010523637A
(ja)
|
2007-04-12 |
2010-07-15 |
エフ．ホフマン−ラ ロシュ アーゲー |
医薬化合物
|
|
GB0707087D0
(en)
|
2007-04-12 |
2007-05-23 |
Piramed Ltd |
Pharmaceutical compounds
|
|
US20100130496A1
(en)
|
2007-04-12 |
2010-05-27 |
F. Hoffmann-La Roche Ag |
Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase
|
|
US8076345B2
(en)
|
2007-04-17 |
2011-12-13 |
Evotec Ag |
2-cyanophenyl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine compounds, compositions and uses thereof
|
|
PE20090717A1
(es)
|
2007-05-18 |
2009-07-18 |
Smithkline Beecham Corp |
Derivados de quinolina como inhibidores de la pi3 quinasa
|
|
EP2154965A4
(en)
|
2007-05-29 |
2011-08-17 |
Glaxosmithkline Llc |
NAPHTHYRIDINE DERIVATIVES AS P13 KINASE INHIBITORS
|
|
ATE510841T1
(de)
|
2007-06-12 |
2011-06-15 |
Hoffmann La Roche |
Thiazoliopyrimidine und ihre verwendung als hemmer der phosphatidylinositol-3 kinase
|
|
WO2008152394A1
(en)
|
2007-06-12 |
2008-12-18 |
F.Hoffmann-La Roche Ag |
Pharmaceutical compounds
|
|
WO2008152387A1
(en)
|
2007-06-12 |
2008-12-18 |
F.Hoffmann-La Roche Ag |
Quinazoline derivatives as pi3 kinase inhibitors
|
|
UY31137A1
(es)
*
|
2007-06-14 |
2009-01-05 |
Smithkline Beecham Corp |
Derivados de quinazolina como inhibidores de la pi3 quinasa
|
|
RU2341527C1
(ru)
|
2007-07-17 |
2008-12-20 |
Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" |
Аннелированные азагетероциклы, включающие пиримидиновый фрагмент, способ их получения и ингибиторы pi3k киназ
|
|
TW200908984A
(en)
|
2007-08-07 |
2009-03-01 |
Piramal Life Sciences Ltd |
Pyridyl derivatives, their preparation and use
|
|
WO2009036768A2
(en)
|
2007-09-19 |
2009-03-26 |
H. Lundbeck A/S |
Diagnosing potential weight gain in a subject
|
|
US20110160232A1
(en)
|
2007-10-04 |
2011-06-30 |
Pingda Ren |
Certain chemical entities and therapeutic uses thereof
|
|
WO2009047255A1
(en)
|
2007-10-09 |
2009-04-16 |
Ucb Pharma, S.A. |
Heterobicyclic compounds as histamine h4-receptor antagonists
|
|
WO2009058361A1
(en)
*
|
2007-10-31 |
2009-05-07 |
Dynavax Technologies Corp. |
Inhibition of type i ifn production
|
|
SG185996A1
(en)
|
2007-11-13 |
2012-12-28 |
Icos Corp |
Inhibitors of human phosphatidyl-inositol 3-kinase delta
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
BRPI0906473A8
(pt)
|
2008-01-04 |
2016-02-10 |
Intellikine Inc |
Certas entidades químicas, composições e métodos
|
|
WO2009120094A2
(en)
|
2008-03-27 |
2009-10-01 |
Auckland Uniservices Limited |
Substituted pyrimidines and triazines and their use in cancer therapy
|
|
US8436005B2
(en)
|
2008-04-03 |
2013-05-07 |
Abbott Laboratories |
Macrocyclic pyrimidine derivatives
|
|
JP5502076B2
(ja)
|
2008-06-05 |
2014-05-28 |
グラクソ グループ リミテッド |
新規化合物
|
|
WO2009147190A1
(en)
|
2008-06-05 |
2009-12-10 |
Glaxo Group Limited |
Novel compounds
|
|
WO2009147188A1
(en)
|
2008-06-05 |
2009-12-10 |
Glaxo Group Limited |
Benzpyrazol derivatives as inhibitors of pi3 kinases
|
|
CN102066365A
(zh)
|
2008-06-19 |
2011-05-18 |
米伦纽姆医药公司 |
噻吩或噻唑衍生物和其作为pi3k抑制剂的用途
|
|
AU2009269087A1
(en)
|
2008-07-07 |
2010-01-14 |
Xcovery Holding Company Llc |
PI3K isoform selective inhibitors
|
|
MX2011000216A
(es)
|
2008-07-08 |
2011-03-29 |
Intellikine Inc |
Inhibidores de cinasa y metodos para su uso.
|
|
BRPI0919816A2
(pt)
*
|
2008-09-26 |
2019-09-24 |
Eisai R&D Man Co Ltd |
uso compostos benzoxazólicos no tratamento de malária
|
|
WO2010036380A1
(en)
|
2008-09-26 |
2010-04-01 |
Intellikine, Inc. |
Heterocyclic kinase inhibitors
|
|
KR20170060179A
(ko)
|
2008-11-13 |
2017-05-31 |
길리아드 칼리스토가 엘엘씨 |
혈액 종양에 대한 요법
|
|
US20110269779A1
(en)
|
2008-11-18 |
2011-11-03 |
Intellikine, Inc. |
Methods and compositions for treatment of ophthalmic conditions
|
|
EP2365810A2
(en)
|
2008-12-04 |
2011-09-21 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Phosphatidylinositol-3-kinase p110 delta-targeted drugs in the treatment of cns disorders
|
|
US8524751B2
(en)
|
2009-03-09 |
2013-09-03 |
GlaxoSmithKline Intellecutual Property Development |
4-oxadiazol-2-YL-indazoles as inhibitors of P13 kinases
|
|
SG174483A1
(en)
|
2009-03-24 |
2011-10-28 |
Univ Singapore |
Use of artemisinin derivatives for the treatment of asthma and chronic obstructive pulmonary disease (copd)
|
|
AU2010229968A1
(en)
|
2009-03-24 |
2011-10-13 |
Gilead Calistoga Llc |
Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
|
|
WO2010120991A1
(en)
*
|
2009-04-17 |
2010-10-21 |
Wyeth Llc |
5, 6, 7, 8-tetrahydropyrido[4,3-d]pyrimidine compounds, their use as mtor, pi3, and hsmg-1 kinase inhibitors, and their syntheses
|
|
JP2012524126A
(ja)
|
2009-04-20 |
2012-10-11 |
ギリアド カリストガ リミテッド ライアビリティ カンパニー |
固形腫瘍の治療方法
|
|
RS53830B1
(sr)
|
2009-04-30 |
2015-06-30 |
Glaxo Group Limited |
Indazoli supstituisani oksazolom kao inhibitori pi3-kinaze
|
|
JP5789252B2
(ja)
*
|
2009-05-07 |
2015-10-07 |
インテリカイン， エルエルシー |
複素環式化合物およびその使用
|
|
MX2011012520A
(es)
|
2009-05-27 |
2011-12-12 |
Hoffmann La Roche |
Compuestos inhibidores de pi3k de pirimidina biciclicos selectivos para p110 delta y metodos de uso de los mismos.
|
|
SG182247A1
(en)
|
2009-05-27 |
2012-08-30 |
Hoffmann La Roche |
Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
|
|
CN102625799A
(zh)
|
2009-06-25 |
2012-08-01 |
安姆根有限公司 |
杂环化合物及其用途
|
|
CA2781865A1
(en)
|
2009-06-25 |
2010-12-29 |
Amgen Inc. |
Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases
|
|
EP2445902A2
(en)
|
2009-06-25 |
2012-05-02 |
Amgen, Inc |
Heterocyclic compounds and their uses as inhibitors of pi3k activity
|
|
JP2012531435A
(ja)
|
2009-06-25 |
2012-12-10 |
アムジエン・インコーポレーテツド |
ＰＩ３Ｋ阻害剤としての４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オン誘導体
|
|
EP2448938B9
(en)
|
2009-06-29 |
2015-06-10 |
Incyte Corporation |
Pyrimidinones as pi3k inhibitors
|
|
KR101745028B1
(ko)
|
2009-07-02 |
2017-06-08 |
사노피 |
신규 ２,３-디히드로-１ｈ-이미다조（１,２-ａ）피리미딘-５-온 유도체, 그의 제조법 및 그의 제약 용도
|
|
PL2448940T3
(pl)
|
2009-07-02 |
2014-10-31 |
Sanofi Sa |
Pochodne 6,7,8,9-tetrahydro-pirymido{1,2-a} pirymidyn-4-onu, ich wytwarzanie i zastosowanie farmaceutyczne
|
|
CA2768843A1
(en)
|
2009-07-21 |
2011-01-27 |
Gilead Calistoga Llc |
Treatment of liver disorders with pi3k inhibitors
|
|
NZ597983A
(en)
|
2009-08-20 |
2014-05-30 |
Karus Therapeutics Ltd |
Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
|
|
US8569296B2
(en)
|
2009-09-29 |
2013-10-29 |
Xcovery Holding Company, Llc |
PI3K (delta) selective inhibitors
|
|
GB0918249D0
(en)
|
2009-10-19 |
2009-12-02 |
Respivert Ltd |
Compounds
|
|
LT2496567T
(lt)
|
2009-11-05 |
2017-11-27 |
Rhizen Pharmaceuticals S.A. |
Nauji benzopirano kinazės moduliatoriai
|
|
US8741932B2
(en)
|
2009-11-06 |
2014-06-03 |
Piramal Enterprises Limited |
Imidazopyridine derivatives
|
|
MX2012005518A
(es)
|
2009-11-13 |
2012-06-19 |
Merck Serono Sa |
Derivados de pirazol amina triciclica.
|
|
EP2507231A1
(en)
|
2009-12-03 |
2012-10-10 |
Glaxo Group Limited |
Indazole derivatives as pi 3 - kinase inhibitors
|
|
WO2011067365A1
(en)
|
2009-12-03 |
2011-06-09 |
Glaxo Group Limited |
Benzpyrazole derivatives as inhibitors of p13 kinases
|
|
WO2011067364A1
(en)
|
2009-12-03 |
2011-06-09 |
Glaxo Group Limited |
Novel compounds
|
|
WO2011075630A1
(en)
|
2009-12-18 |
2011-06-23 |
Incyte Corporation |
Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors
|
|
WO2011075643A1
(en)
|
2009-12-18 |
2011-06-23 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as pi3k inhibitors
|
|
US8633313B2
(en)
|
2009-12-18 |
2014-01-21 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
|
MX2012009059A
(es)
|
2010-02-22 |
2012-09-07 |
Hoffmann La Roche |
Compuestos inhibidores de fosfoinositida 3-cinasa delta (pi3k) pirido [3,2-d]pirimidina y metodos de uso.
|
|
UY33304A
(es)
|
2010-04-02 |
2011-10-31 |
Amgen Inc |
Compuestos heterocíclicos y sus usos
|
|
EP2558463A1
(en)
|
2010-04-14 |
2013-02-20 |
Incyte Corporation |
Fused derivatives as i3 inhibitors
|
|
GB201007347D0
(en)
|
2010-04-30 |
2010-06-16 |
Karus Therapeutics Ltd |
Compounds
|
|
JP5951600B2
(ja)
|
2010-05-21 |
2016-07-13 |
インフィニティー ファーマシューティカルズ， インコーポレイテッド |
キナーゼ調節のための、化合物、組成物および方法
|
|
US9062055B2
(en)
|
2010-06-21 |
2015-06-23 |
Incyte Corporation |
Fused pyrrole derivatives as PI3K inhibitors
|
|
UA112517C2
(uk)
*
|
2010-07-06 |
2016-09-26 |
Новартіс Аг |
Тетрагідропіридопіримідинові похідні
|
|
MX2013000389A
(es)
|
2010-07-14 |
2013-03-08 |
Hoffmann La Roche |
Compuestos de purina selectivos para fosfatidilinositol 3-cinasa p110 delta, y metodods de uso.
|
|
EP2616469B1
(en)
|
2010-09-14 |
2016-10-26 |
Exelixis, Inc. |
9h-purine compounds as pi3k-delta inhibitors and methods for their manufacture
|
|
TWI642670B
(zh)
|
2010-09-14 |
2018-12-01 |
伊塞利克斯公司 |
Ｐｉ３ｋ-德爾塔抑制劑以及其應用和生產方法
|
|
EP3238722B1
(en)
|
2011-01-10 |
2019-03-13 |
Infinity Pharmaceuticals, Inc. |
Solid forms of isoquinolinones
|
|
US9108984B2
(en)
|
2011-03-14 |
2015-08-18 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
|
|
KR20140032383A
(ko)
|
2011-03-21 |
2014-03-14 |
에프. 호프만-라 로슈 아게 |
Pi3k p110 델타에 대하여 선택적인 벤즈옥사제핀 화합물 및 이의 사용 방법
|
|
US9126948B2
(en)
|
2011-03-25 |
2015-09-08 |
Incyte Holdings Corporation |
Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
|
|
CA2831590A1
(en)
|
2011-03-28 |
2012-10-04 |
Mei Pharma, Inc. |
(alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
|
|
US8530470B2
(en)
|
2011-04-13 |
2013-09-10 |
Astrazeneca Ab |
Chromenone derivatives
|
|
EP2518071A1
(en)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Imidazopyridine derivatives as PI3K inhibitors
|
|
EP2518070A1
(en)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as PI3K inhibitors
|
|
WO2013057711A1
(en)
*
|
2011-10-21 |
2013-04-25 |
Novartis Ag |
Quinazoline derivatives as pi3k modulators
|
|
ES2661510T3
(es)
|
2011-12-15 |
2018-04-02 |
Novartis Ag |
Uso de inhibidores de la actividad o función de PI3K
|